549 related articles for article (PubMed ID: 25548186)
1. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance.
Maldonado RA; LaMothe RA; Ferrari JD; Zhang AH; Rossi RJ; Kolte PN; Griset AP; O'Neil C; Altreuter DH; Browning E; Johnston L; Farokhzad OC; Langer R; Scott DW; von Andrian UH; Kishimoto TK
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):E156-65. PubMed ID: 25548186
[TBL] [Abstract][Full Text] [Related]
2. Tolerogenic nanoparticles to induce immunologic tolerance: Prevention and reversal of FVIII inhibitor formation.
Zhang AH; Rossi RJ; Yoon J; Wang H; Scott DW
Cell Immunol; 2016 Mar; 301():74-81. PubMed ID: 26687613
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles for the Induction of Antigen-Specific Immunological Tolerance.
Kishimoto TK; Maldonado RA
Front Immunol; 2018; 9():230. PubMed ID: 29515571
[TBL] [Abstract][Full Text] [Related]
4. Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles.
Kishimoto TK; Ferrari JD; LaMothe RA; Kolte PN; Griset AP; O'Neil C; Chan V; Browning E; Chalishazar A; Kuhlman W; Fu FN; Viseux N; Altreuter DH; Johnston L; Maldonado RA
Nat Nanotechnol; 2016 Oct; 11(10):890-899. PubMed ID: 27479756
[TBL] [Abstract][Full Text] [Related]
5. Tolerogenic Nanoparticles Induce Antigen-Specific Regulatory T Cells and Provide Therapeutic Efficacy and Transferrable Tolerance against Experimental Autoimmune Encephalomyelitis.
LaMothe RA; Kolte PN; Vo T; Ferrari JD; Gelsinger TC; Wong J; Chan VT; Ahmed S; Srinivasan A; Deitemeyer P; Maldonado RA; Kishimoto TK
Front Immunol; 2018; 9():281. PubMed ID: 29552007
[TBL] [Abstract][Full Text] [Related]
6. An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis.
Cho JJ; Stewart JM; Drashansky TT; Brusko MA; Zuniga AN; Lorentsen KJ; Keselowsky BG; Avram D
Biomaterials; 2017 Oct; 143():79-92. PubMed ID: 28772190
[TBL] [Abstract][Full Text] [Related]
7. A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease.
Hunter Z; McCarthy DP; Yap WT; Harp CT; Getts DR; Shea LD; Miller SD
ACS Nano; 2014 Mar; 8(3):2148-60. PubMed ID: 24559284
[TBL] [Abstract][Full Text] [Related]
8. Induction of tolerance to factor VIII by transient co-administration with rapamycin.
Moghimi B; Sack BK; Nayak S; Markusic DM; Mah CS; Herzog RW
J Thromb Haemost; 2011 Aug; 9(8):1524-33. PubMed ID: 21585650
[TBL] [Abstract][Full Text] [Related]
9. Controlled Delivery of Single or Multiple Antigens in Tolerogenic Nanoparticles Using Peptide-Polymer Bioconjugates.
Pearson RM; Casey LM; Hughes KR; Wang LZ; North MG; Getts DR; Miller SD; Shea LD
Mol Ther; 2017 Jul; 25(7):1655-1664. PubMed ID: 28479234
[TBL] [Abstract][Full Text] [Related]
10. Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance.
Kuo R; Saito E; Miller SD; Shea LD
Mol Ther; 2017 Jul; 25(7):1676-1685. PubMed ID: 28408181
[TBL] [Abstract][Full Text] [Related]
11. Tolerogenic Nanoparticles Impacting B and T Lymphocyte Responses Delay Autoimmune Arthritis in K/BxN Mice.
Srivastava A; Arlian BM; Pang L; Kishimoto TK; Paulson JC
ACS Chem Biol; 2021 Oct; 16(10):1985-1993. PubMed ID: 34037371
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin.
Biswas M; Rogers GL; Sherman A; Byrne BJ; Markusic DM; Jiang H; Herzog RW
Thromb Haemost; 2017 Jan; 117(1):33-43. PubMed ID: 27683758
[TBL] [Abstract][Full Text] [Related]
13. B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.
Sun JB; Czerkinsky C; Holmgren J
J Immunol; 2012 Feb; 188(4):1686-97. PubMed ID: 22250081
[TBL] [Abstract][Full Text] [Related]
14. Different mechanisms regulate CD4(+) T cell independent induction of oral and nasal tolerance of CD8(+) T cells.
van den Berg H; Greuter M; Kraal G; den Haan JM
Immunobiology; 2010; 215(2):163-71. PubMed ID: 19278748
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis.
Cappellano G; Woldetsadik AD; Orilieri E; Shivakumar Y; Rizzi M; Carniato F; Gigliotti CL; Boggio E; Clemente N; Comi C; Dianzani C; Boldorini R; Chiocchetti A; RenĂ² F; Dianzani U
Vaccine; 2014 Sep; 32(43):5681-9. PubMed ID: 25149432
[TBL] [Abstract][Full Text] [Related]
16. Improvement of adaptive immunity by antigen-carrying biodegradable nanoparticles.
Uto T; Wang X; Akagi T; Zenkyu R; Akashi M; Baba M
Biochem Biophys Res Commun; 2009 Feb; 379(2):600-4. PubMed ID: 19121627
[TBL] [Abstract][Full Text] [Related]
17. Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: A comparative study of cationic liposomes and PLGA nanoparticles.
Varypataki EM; Silva AL; Barnier-Quer C; Collin N; Ossendorp F; Jiskoot W
J Control Release; 2016 Mar; 226():98-106. PubMed ID: 26876760
[TBL] [Abstract][Full Text] [Related]
18. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
19. Immune responses to vaccines involving a combined antigen-nanoparticle mixture and nanoparticle-encapsulated antigen formulation.
Zhang W; Wang L; Liu Y; Chen X; Liu Q; Jia J; Yang T; Qiu S; Ma G
Biomaterials; 2014 Jul; 35(23):6086-97. PubMed ID: 24780166
[TBL] [Abstract][Full Text] [Related]
20. Specific immunological non-responsiveness induced by antigens via mucosal surfaces.
Metzler B; Wraith DC
Adv Exp Med Biol; 1995; 371B():1243-4. PubMed ID: 7502792
[No Abstract] [Full Text] [Related]
[Next] [New Search]